Mary Sheehan
Addiction Psychiatry · Tampa, FLNPI 1407869829
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Indivior Inc. accounts for 73.0% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $11,186 and has fallen 98.3% since, to $193 in 2025.
Across 173 payments — averaging $90.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$11K
- Johnson & Johnson$753
- Sunovion Pharmaceuticals Inc.$520
- AbbVie$511
- Neurocrine Biosciences, Inc.$487
- Otsuka America Pharmaceutical, Inc.$431
- plus $2K from 13 others
What the payments were for
- Consulting fees$2,22014%
- Speaking & faculty fees$7,70049%
- Travel & lodging$8225%
- Food & beverage$4,86231%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 27 | $11,394 |
| Johnson & Johnson | 41 | $753 |
| Sunovion Pharmaceuticals Inc. | 20 | $520 |
| AbbVie(2 entities) | 15 | $511 |
| Neurocrine Biosciences, Inc. | 19 | $487 |
| Otsuka America Pharmaceutical, Inc. | 19 | $431 |
| Eisai Inc. | 3 | $271 |
| Alkermes, Inc. | 15 | $259 |
| Jazz Pharmaceuticals Inc. | 2 | $244 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $165 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Livanova USA, Inc. | 1 | $121 |
| Braeburn Inc. | 1 | $91 |
| E.r. Squibb & Sons, L.L.C. | 1 | $90 |
| Neuronetics, Inc. | 1 | $54 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PERSERIS$11,247
- INVEGA SUSTENNA$345
- LATUDA$249
- Dayvigo$246
- VRAYLAR$222
- CAPLYTA$143
- Auvelity$125
- SUNOSI$123
- VNS - Symmetry$121
- INVEGA TRINZA$121
- ABILIFY MAINTENA$116
- INGREZZA$103
How this compares
$15,604 in reported general payments places this provider in the 85th percentile of 29 addiction psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 15 | $1,673 |
Paid to pharmacies, not to this prescriber.
Other addiction psychiatry in Tampa
- Michael AdamsTampa$863
- Woodburne LevyTampa$237
- Elie FrancisTampa$204
- Walid AzizTampa$71
- Alexander SinuTampa$61
- Sarah HeitnerTampa$7
- Raul RodriguezDelray Beach$31K
- Jason FieldsNew Port Richey$26K
- Edward BariasJupiter$21K
- Aldo MoralesFort Lauderdale$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.